F.D.A. Faces Upset Over Denials of New Drugs

by | Mar 5, 2026 | Politics

Spread the love
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments